M.S. is a disease of the brain and spinal cord that affects almost a million people in the United States. About 1,200 here in ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Black people with MS walk slower and cover shorter distances than white patients, even when some social determinants are ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Relapses were thought to drive disability progression with RRMS, but PIRA may be an important contributor, affecting patients ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

Among patients with multiple sclerosis, depression or anxiety are associated with being on Medicaid, clinical relapse, and DMT delay.

Patients with long-term health conditions in part of north Devon have said they face round-trips of more than 60 miles for ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...